Sangamo Therapeutics Q4 EPS $(0.34) Misses $(0.26) Estimate, Sales $2.04M Miss $8.10M Estimate
Sangamo Therapeutics Q4 EPS $(0.34) Misses $(0.26) Estimate, Sales $2.04M Miss $8.10M Estimate
Sangamo Therapeutics第四季度每股收益美元（0.34）未达到预期（0.26美元），销售额204万美元低于810万美元的预期
Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.26) by 30.77 percent. This is a 6.25 percent decrease over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $2.04 million which missed the analyst consensus estimate of $8.10 million by 74.79 percent. This is a 92.50 percent decrease over sales of $27.23 million the same period last year.
Sangamo Therapeutics（纳斯达克股票代码：SGMO）公布的季度亏损为每股0.34美元，比分析师普遍预期的0.26美元（0.26美元）低30.77个百分点。与去年同期每股亏损0.32美元（0.32美元）相比，下降了6.25％。该公司公布的季度销售额为204万美元，比分析师普遍预期的810万美元低74.79％。这比去年同期的2723万美元的销售额下降了92.50％。